Vaxart Inc Stock Filter Stocks by Fundamentals
| VXRT Stock | USD 0.61 0.01 1.67% |
Vaxart Inc fundamentals help investors to digest information that contributes to Vaxart's financial success or failures. It also enables traders to predict the movement of Vaxart Stock. The fundamental analysis module provides a way to measure Vaxart's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vaxart stock.
Vaxart | Shares Owned by Institutions |
Vaxart Current Valuation Drivers
We derive many important indicators used in calculating different scores of Vaxart from analyzing Vaxart's financial statements. These drivers represent accounts that assess Vaxart's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Vaxart's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 7.5M | 504.2M | 761.5M | 122.6M | 83.0M | 139.5M | |
| Enterprise Value | (3.7M) | 384.5M | 630.8M | 100.3M | 74.7M | 127.8M |
Vaxart Institutional Holders
Institutional Holdings refers to the ownership stake in Vaxart that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Vaxart's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Vaxart's value.| Shares | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 186.6 K | Bank Of America Corp | 2024-06-30 | 166.2 K | Monaco Asset Management | 2024-09-30 | 164.3 K | Qube Research & Technologies | 2024-06-30 | 163.6 K | Charles Schwab Investment Management Inc | 2024-09-30 | 153.5 K | Xtx Topco Ltd | 2024-09-30 | 136.5 K | Two Sigma Investments Llc | 2024-09-30 | 111.1 K | Simplex Trading, Llc | 2024-06-30 | 98.3 K | Group One Trading, Lp | 2024-06-30 | 84.4 K | Sio Capital Management, Llc | 2024-09-30 | 13.6 M | Vanguard Group Inc | 2024-09-30 | 10.1 M |
Vaxart Fundamentals
| Return On Equity | -0.92 | ||||
| Return On Asset | -0.4 | ||||
| Operating Margin | (2.54) % | ||||
| Current Valuation | 98.73 M | ||||
| Shares Outstanding | 227.48 M | ||||
| Shares Owned By Insiders | 0.87 % | ||||
| Shares Owned By Institutions | 17.80 % | ||||
| Number Of Shares Shorted | 11.27 M | ||||
| Price To Book | 2.03 X | ||||
| Price To Sales | 10.00 X | ||||
| Revenue | 7.38 M | ||||
| Gross Profit | (80.95 M) | ||||
| EBITDA | (74.72 M) | ||||
| Net Income | (82.47 M) | ||||
| Cash And Equivalents | 129.55 M | ||||
| Cash Per Share | 1.02 X | ||||
| Total Debt | 26.51 M | ||||
| Debt To Equity | 0.09 % | ||||
| Current Ratio | 8.65 X | ||||
| Book Value Per Share | 0.38 X | ||||
| Cash Flow From Operations | (70.45 M) | ||||
| Short Ratio | 11.71 X | ||||
| Earnings Per Share | (0.40) X | ||||
| Target Price | 4.83 | ||||
| Number Of Employees | 109 | ||||
| Beta | 0.7 | ||||
| Market Capitalization | 139.24 M | ||||
| Total Asset | 91.83 M | ||||
| Retained Earnings | (409.57 M) | ||||
| Working Capital | 31.81 M | ||||
| Net Asset | 91.83 M |
About Vaxart Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vaxart Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vaxart using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vaxart Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Vaxart Stock Analysis
When running Vaxart's price analysis, check to measure Vaxart's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxart is operating at the current time. Most of Vaxart's value examination focuses on studying past and present price action to predict the probability of Vaxart's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxart's price. Additionally, you may evaluate how the addition of Vaxart to your portfolios can decrease your overall portfolio volatility.